Carl L. Nelson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Carl L. Nelson has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
Robert A. Skinner
Department of Orthopaedic Surgery. University of Arkansas Medical Sciences, Little Rock, Akansas, U.S.A.
1 shared publicationSandra G. Hickmon
Department of Orthopaedic Surgery. University of Arkansas Medical Sciences, Little Rock, Akansas, U.S.A.
1 shared publication
Latest Publications
- 1 March 1997
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 15 (2) , 249-255
Treatment of experimental osteomyelitis by surgical debridement and the implantation of bioerodable, polyanhydride‐gentamicin beads
Osteomyelitis was induced in the radius in 77 rabbits and confirmed by histological examination and culture. At 4 weeks, the wounds were debrided and the animals were treated with (a) fatty acid dimersebacic acid beads (a bioerodable composite) impregnated with 20% or (b) 10% gentamicin sulfate, (c) placebo beads and intramuscular gentamicin sulfate. (d) placebo beads alone, or (e) debridement only. After 4 weeks, eradication of infection was determined by histological examination and culture. Osteomyelitis was eradicated in 93% of the animals treated with the beads and 20% gentamicin, in 67% of those treated with the beads arid 10% gentamicin, in 25% of those treated with placebo beads and intramuscular gentamicin, in 7% of those treated with placebo beads alone, and in 12.5% of those treated with debridement only (p values from <0.001 to 0.02). Fatty acid dimer‐sehacie acid beads with gentamicin were then implanted in noninfected rabbits, and gentamicin sulfate concentrations in bone, serum, urine, and wound exudate were measured. Gentamicin sulfate was detectable in bone for as long as 8 weeks after implantation. Levels as high as 4,746 g/ml were present in the wound exudate for the first 7 days. Levels in the serum peaked at 1.03 μg/ml. Urine levels peaked at 135 μg/ml.
- 1 March 1997
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 15 (2) , 249-255
Treatment of experimental osteomyelitis by surgical debridement and the implantation of bioerodable, polyanhydride‐gentamicin beads
Osteomyelitis was induced in the radius in 77 rabbits and confirmed by histological examination and culture. At 4 weeks, the wounds were debrided and the animals were treated with (a) fatty acid dimersebacic acid beads (a bioerodable composite) impregnated with 20% or (b) 10% gentamicin sulfate, (c) placebo beads and intramuscular gentamicin sulfate. (d) placebo beads alone, or (e) debridement only. After 4 weeks, eradication of infection was determined by histological examination and culture. Osteomyelitis was eradicated in 93% of the animals treated with the beads and 20% gentamicin, in 67% of those treated with the beads arid 10% gentamicin, in 25% of those treated with placebo beads and intramuscular gentamicin, in 7% of those treated with placebo beads alone, and in 12.5% of those treated with debridement only (p values from <0.001 to 0.02). Fatty acid dimer‐sehacie acid beads with gentamicin were then implanted in noninfected rabbits, and gentamicin sulfate concentrations in bone, serum, urine, and wound exudate were measured. Gentamicin sulfate was detectable in bone for as long as 8 weeks after implantation. Levels as high as 4,746 g/ml were present in the wound exudate for the first 7 days. Levels in the serum peaked at 1.03 μg/ml. Urine levels peaked at 135 μg/ml.